President Uhuru Kenyatta has called on all Kenyans rally under the call of 25 days before Christmass to secure Covid-19 vaccinations.
Speaking during the State of the Nation address, Kenyatta said that a shot in the arm will be safe for the country’s economy help it to return to normal.
“I promised 10 million to be vaccinated by December, we are at 7 million. I urge all to get the jab. Let’s err on the side of caution, protect our lives and those of all Kenyans,” he said.
He said the Covid-19 vaccines are in stock across the country and in all counties with a daily avaerage rate of over 100,000 vaccination.
Kenyatta has invited the media to use their plaform to perform their social good and promote vaccination campaign.
On the new variant, Omicron, Kenyatta said the variant may explain infection rate spikes across the globe.
He also called on foreign countries not to close their borders over the Omicron variant stating that Covid-19 will not be defeated by locking boarders down or shutting off parts of the world that are problematic.
“No one will be safe until we are all safe,” he said.
While outlining eight-point economic stimulus programme to help keep the country afloat, the Head of State recognised Revital Healthcare (EPZ), a Kenyan medical supply manufacturer, for being the continent’s largest producer of COVID-19 vaccines syringes.
He acknowledged the efforts of the Kilifi-based company in spearheading the Country’s economy in terms of innovation in the manufacturing industry.
A Kenyan company known as Revital operating in Kilifi County in Coast region became Africa’s largest producer and exporter of COVID-19 vaccine syringes during the COVID period,” he said.
According to Kenyatta, in 2020 alone, Revital exported 70 million COVID-19 syringes to over 20 countries globally.
He lauded the company’s role in the fight against the COVID-19 virus since its resurgence in early 2020 and the economic role it is going to play in the future.
“In fact, Revital currently has the capacity to produce 300 million Covid vaccine syringes every year. The global shortage for the COVID-19 syringes stands at 2 billion and this alone is taking advantage of opportunities,” he noted.
